Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

15.8K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.8K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.7K
4.7K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

2.2K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.2K
Protein-protein Interfaces02:04

Protein-protein Interfaces

15.1K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

10.0K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
10.0K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

2.1K
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Governing real-world health data as a public utility.

Science (New York, N.Y.)·2026
Same author

AI-powered programmable virtual humans toward human physiologically-based drug discovery.

Drug discovery today·2025
Same author

CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13.

Journal of chemical information and modeling·2025
Same author

Biological databases in the age of generative artificial intelligence.

Bioinformatics advances·2025
Same author

Exploring Extended Warheads toward Developing Cysteine-Targeted Covalent Kinase Inhibitors.

Journal of chemical information and modeling·2024
Same author

Deep generative models of protein structure uncover distant relationships across a continuous fold space.

Nature communications·2024

Related Experiment Video

Updated: Apr 21, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.7K

Deciphering covalent kinase inhibitor binding landscape through structural kinome profiling.

Zheng Zhao1, Philip E Bourne1

  • 1School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, 22904, United States of America.

European Journal of Medicinal Chemistry
|April 19, 2026
PubMed
Summary
This summary is machine-generated.

This study presents a comprehensive structural resource for kinases and covalent kinase inhibitors (CKIs), detailing their binding modes and interactions. These findings support the development of novel kinase-targeted therapies.

Keywords:
Covalent kinaseInhibitorsInteraction fingerprintsKinase databaseKinase drug designKinase-covalent binding interactionsStructural kinome analysis

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.4K
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.8K

Related Experiment Videos

Last Updated: Apr 21, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.7K
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

8.4K
Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

6.8K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Medicinal Chemistry

Background:

  • Kinase-targeted drugs represent significant progress, with 100 FDA-approved therapies and numerous preclinical candidates.
  • Over 180 kinases are implicated in disease, highlighting the ongoing need for novel drug discovery.
  • Covalent kinase inhibitors (CKIs) offer enhanced selectivity through covalent interactions with kinase targets.

Purpose of the Study:

  • To create comprehensive structural kinome resources from PDB data.
  • To systematically investigate the binding characteristics of CKIs.
  • To provide insights supporting future kinase-targeted drug design.

Main Methods:

  • Collation of all kinase structures from the Protein Data Bank (PDB) into dedicated databases.
  • Analysis of kinase domain structures (6969 PDB structures).
  • Investigation of kinase-CKI complex structures (325 PDB structures) to understand binding modes, interactions, warheads, and nucleophilic amino acids.

Main Results:

  • Development of three structural kinome resources: kinase domain, ligand-binding, and CKI complex databases.
  • Systematic analysis of CKI binding modes, interaction fingerprints, electrophilic warheads (21 types), and nucleophilic amino acids (64 types in 15 positions).
  • Inclusion of information on covalent degraders and multi-warhead CKIs.

Conclusions:

  • The established structural kinase resources offer comprehensive insights into CKI binding properties.
  • These resources are valuable for advancing the design of novel kinase-targeted drugs.
  • The databases are publicly accessible for research use.